Drawing on emerging research in newborn genomic screening, including studies led by Dr. Robert Green, this Opinion piece examines both the promise and complexity of using genome sequencing in newborn care. Daniela Lamas examines questions about uncertainty, parental decision-making, and the future of genomic newborn screening as large-scale studies begin enrolling tens of thousands of infants.
